Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials

INTRODUCTION: Myasthenia gravis (MG), a rare neuromuscular disease, is often initially treated using acetylcholinesterase inhibitors. Patients who do not respond adequately depend on the use of corticosteroids or other immunosuppressive medication, but these may have serious side effects. Clinical o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMJ Open
Autores principales: Vrinten, Charlotte, Lipka, Alexander F, van Zwet, Erik W, Schimmel, Kirsten J M, Cornel, Martina C, Kuijpers, Marja R, Hekster, Yechiel A, Weinreich, Stephanie S, Verschuuren, Jan J G M
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2015
Materias:
Neurology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4513481/
https://ncbi.nlm.nih.gov/pubmed/26185179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-007863
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares